Logo 1 Logo 2

Clinical Trial Details

Trial ID: L4816
Source ID: NCT01798914
Associated Drug: Technosphere Insulin Inhalation Powder
Title: Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder
Acronym:
Status: NO_LONGER_AVAILABLE
Study Results: NO
Results:
Conditions: Type 1 Diabetes|Type 2 Diabetes
Interventions: DRUG: Technosphere Insulin Inhalation Powder
Outcome Measures:
Sponsor/Collaborators: Sponsor: Mannkind Corporation
Gender: ALL
Age: CHILD, ADULT, OLDER_ADULT
Phases:
Enrollment:
Study Type: EXPANDED_ACCESS
Study Designs:
Start Date: 2008-10
Completion Date: 2015-05
Results First Posted:
Last Update Posted: 2016-01-20
Locations: Endocrinology Associates, Montgomery, Alabama, 36106, United States|Diabetes and Endocrine Consultants P.C., Montgomery, Alabama, 36117, United States|University of Miami Diabetes Research Institute, Miami, Florida, 33136, United States|Dr. Rife and Associates Family Medicine, Orland Park, Illinois, 60467, United States|Highland Clini-Endocrinology, Shreveport, Louisiana, 71105, United States|Annapolis Internal Medicine LLC, Annapolis, Maryland, 21401, United States|Nallin Family Healthcare, Cumberland, Maryland, 21502, United States|Center for Diabetes and Endocrinology, Portsmouth, New Hampshire, 03801, United States|North Country Community Physicians, Glen Cove, New York, 11542, United States|Great Neck Medical Group, Great Neck, New York, 11021, United States|North Shore Diabetes and Endocrine Associates, New Hyde Park, New York, 11042, United States|Mountain Diabetes and Endocrine Center, Asheville, North Carolina, 28803, United States|Primary Care Wakefield, Wakefield, Rhode Island, 02879, United States|Endocrinology Associates Inc., Roanoke, Virginia, 24016, United States
URL: https://clinicaltrials.gov/show/NCT01798914

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress